Management of Type-I Diabetes: A Right Procedure to Normal Life Expectancy

Devajit Mohajan and Haradhan Kumar Mohajan
Additional contact information
Devajit Mohajan: Department of Civil Engineering, Chittagong University of Engineering & Technology, Chittagong, Bangladesh
Haradhan Kumar Mohajan: Department of Mathematics, Premier University, Chittagong, Bangladesh

Frontiers in Management Science, 2023, vol. 2, issue 6, 47-53

Abstract: Management of type 1 diabetes (T1D) is a great challenge for the healthcare professionals and at present there is no known strategy to prevent it. The common symptoms of T1D are polyuria, polydipsia, weight loss, hypoglycaemia, marked hyperglycaemia, ketonemia, and insulin deficiency with nonresponsive to oral agents. It is a life-threatening multifactorial autoimmune disease with progressive β-cell destruction that leads to severe endogenous insulin deficiency. The scientists are not sure why these β-cells are damaged. T1D is incurable and usually treated with lifelong insulin injections and careful attention to diet and physical activity. As a result, ultimately the patients become physiological dependence on exogenous insulin. The purpose of this study is to provide various information and treatment strategy of type 1 diabetes (T1D).

Keywords: Type 1 diabetes; insulin; β-cells; hyperglycaemia; hypoglycaemia (search for similar items in EconPapers)
Date: 2023
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.paradigmpress.org/fms/article/view/939/813 (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:bdz:frmans:v:2:y:2023:i:6:p:47-53

DOI: 10.56397/FMS.2023.12.07

Access Statistics for this article

More articles in Frontiers in Management Science from Paradigm Academic Press
Bibliographic data for series maintained by Editorial Office ().